MedDataX Logo

Intra-operative Pancreatoscopy in Patients With IPMN

NCT ID: NCT03729453

Last Updated: 2025-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-03-20

Study Completion Date

2027-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas; to generate a hypothesis for a subsequent randomized control trial.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SpyGlass in Preoperative Diagnostics of Presumed Main Duct IPMNs: Efficacy and Novel Insights on Complications

NCT03062124

Intraductal Papillary Mucinous Neoplasm
COMPLETED

Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy

NCT03738787

Pancreatic Fistula Pancreatic Neoplasms Postoperative Complications
COMPLETED PHASE2

New Technique of End-to-Side Two-Layered Duct-to-Mucosa Pancreaticojejunostomy With Omental Wrapping and Glue (Glubran 2) During Laparoscopic Whipple Operation

NCT07333755

Periampullary Carcinoma Resectable
COMPLETED PHASE4

Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS

NCT02524418

Biliary Tract Disease
COMPLETED NA

SpyGlass™ Discover Percutaneous

NCT04580940

Pancreatic Diseases Bile Duct Obstruction Bile Duct Diseases
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study is to demonstrate the added value of intraoperative pancreatoscopy in patients undergoing partial pancreatic resection for the treatment of Intraductal Papillary Mucinous Neoplasm (IPMN) as it pertains to detection of discontinuous (skip) lesions in the remnant pancreas. A secondary study objective is to generate a hypothesis for a subsequent randomized controlled trial comparing diagnostic accuracy of intra-operative pancreatoscopy and SpyBite™ with the diagnostic accuracy of intra-operative frozen section in patients undergoing resection

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intraductal Papillary Mucinous Neoplasm

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intraoperative Pancreatoscopy

All subjects will undergo the intraoperative pancreatoscopy with SpyGlass procedure.

SpyGlass

Intervention Type DEVICE

Visualization of main pancreatic duct with SpyGlass catheter.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SpyGlass

Visualization of main pancreatic duct with SpyGlass catheter.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient scheduled for surgery for suspected MD-IPMN or Mixed IPMN within 4-6 weeks of enrollment
2. Diameter of pancreatic main duct \>5mm on pre-operative MRI or CT
3. Written informed consent from patient to participate in the study, including compliance with study procedures

Exclusion Criteria

1. Contraindication for pancreatoscopy
2. Age: less than 18 years
3. Pregnant women, evaluated per local clinical standard
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boston Scientific Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marco Del Chiaro, MD

Role: PRINCIPAL_INVESTIGATOR

University of Colorado, Denver

G.V. Rao, MD

Role: PRINCIPAL_INVESTIGATOR

Asian Institute of Gastroenterology

Richard Burkhart, MD

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University

Marc Besselink, MD

Role: PRINCIPAL_INVESTIGATOR

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Yi Miao, MD

Role: PRINCIPAL_INVESTIGATOR

Nanjing Medical University

Sohei Satoi, MD

Role: PRINCIPAL_INVESTIGATOR

Kansai Medical University

Urban Arnelo, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Umeå

Christian Schmidt, MD

Role: PRINCIPAL_INVESTIGATOR

Indiana University Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Colorado Hospital

Denver, Colorado, United States

Site Status

Indiana University Health

Indianapolis, Indiana, United States

Site Status

Johns Hopkins Hospital University

Baltimore, Maryland, United States

Site Status

The First Affiliated Hospital of Nanjing Medical University

Nanjing, , China

Site Status

Asian Institute of Gastroenterology

Hyderabad, , India

Site Status

Kansai Medical University

Hirakata, Osaka, Japan

Site Status

Academic Medical Center

Amsterdam, , Netherlands

Site Status

University Hospital of UMEA

Umeå, , Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States China India Japan Netherlands Sweden

References

Explore related publications, articles, or registry entries linked to this study.

Grewal M, Habib JR, Paluszek O, Cohen SM, Wolfgang CL, Javed AA. The Role of Intraoperative Pancreatoscopy in the Surgical Management of Intraductal Papillary Mucinous Neoplasms: A Scoping Review. Pancreas. 2024 Mar 1;53(3):e280-e287. doi: 10.1097/MPA.0000000000002294. Epub 2024 Jan 26.

Reference Type DERIVED
PMID: 38277399 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E7107

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

SpyGlass Surgical Study
NCT05822635 COMPLETED
Evaluation of the SpyGlass DS for Detection of Residual Pancreatic Calculations
NCT04672642 COMPLETED NA
Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3)
NCT06939023 RECRUITING NA
Application of 2D and 3D Laparoscopy in Laparoscopic Pancreaticoduodenectomy: a Prospective Randomized Clinical Trial
NCT03754595 UNKNOWN NA
Minimally Invasive Robot-assisted and Laparoscopic Distal Pancreatectomy in a Pan-European Registry
NCT06160154 COMPLETED
Digital Catheter Based Pancreatoscopy (SpyGlassDS) for the Management of Symptomatic Pancreatic Duct Stones in Selected Patients With Chronic Pancreatitis
NCT04131010 UNKNOWN NA
Clinical Utility of the Spyglass System in Primary Sclerosing Cholangitis (PSC)
NCT01556555 COMPLETED
Endoscopic Evaluation of Premalignant Lesions in the Biliary Tract and Pancreatic Ducts
NCT02057146 COMPLETED NA
Effectiveness of Metal Protheses Covered in "Diabolo" in Treatment of Necrosis of Origin Pancreatic: Trial "DIABOLOPIG"
NCT02739074 COMPLETED
ERCP in Idiopathic Recurrent Acute Pancreatitis
NCT01583517 COMPLETED NA
Percutaneous Lesioning Splanchnic Nerves in Patients With Chronic Pancreatitis
NCT01005017 UNKNOWN NA
Cholangioscopic Classification of Bile Duct Lesions
NCT02794987 COMPLETED
Laparoscopy to Remove Pancreatic Tumors (Insulinomas)
NCT00005910 COMPLETED NA
Laparoscopic Versus Open Pancreatectomy
NCT00988793 WITHDRAWN NA
Endoscopic Retrograde Cholangiopancreatography (ERCP) With Cholangiopancreatoscopy Using a Thin Scope
NCT01242995 WITHDRAWN
Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
NCT00609726 COMPLETED
Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic .
NCT03140007 UNKNOWN NA
A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy
NCT02270554 COMPLETED PHASE2
Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor
NCT00930410 COMPLETED NA
Immediate vs. On-demand Endoscopic Necrosectomy in Infected Walled-off Pancreatic Necrosis
NCT05530772 COMPLETED NA
Incidence, Risk Factors and Endoscopic Retrieval of Proximally Migrated Pancreatic Stents
NCT05431517 COMPLETED
Laparoscopic Enucleation of Frantz's Tumor of the Pancreas
NCT04728750 COMPLETED
Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy
NCT04171440 COMPLETED NA
Three-Dimensional Vascular Reconstruction of the Pancreas on Multidetector Computed Tomography Images and Its Impact on Patients Undergoing Pancreaticoduodenectomy
NCT05389917 UNKNOWN
Prophylactic Pancreatic Duct Stent Placement After ESP of Major Papillary Tumors; Prospective, Randomized Study
NCT01737463 UNKNOWN PHASE4